By treating distinct validation guidelines as decision-making units, data envelopment analysis (DEA) allows for the mathematical evaluation of their resource efficiency.
- CDMO Selection Beyond Capabilities And Price
- August 2026 — CDMO Opportunities And Threats Report
- ICH M4Q(R2) And M16 Modernize The CTD For Digital Submissions
- Inside Scaling Next-Gen MSCs Without Scaling Risk
- Building Sustainable Biopharma Supply Chains Starts With Procurement
- Sustainable Facility Design Brings Bayer Instant Savings
- In Case You Missed Them: Recapping The FDA's Recent Guidances For Cell And Gene Therapies
- Why You Should Measure Comparability Debt Before Ever Starting A Study
CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![GettyImages-2183428964 lab]( "Comparison Of Single-Use And Steel Fermentors For Malaria Vaccine Production")
Comparison Of Single-Use And Steel Fermentors For Malaria Vaccine ProductionSupport the advancement of malaria vaccine development by leveraging innovative bioprocessing solutions to enable efficient, scalable, and accessible vaccine production worldwide.
-
![GettyImages-1180581753-scientists-lab-monitoring-computer-laboratory]( "Achieving High Cell Purity With The CTS DynaCellect Magnetic Separation System")
Achieving High Cell Purity With The CTS DynaCellect Magnetic Separation SystemLearn how closed-system automation, combined with expert technical guidance and protocol optimization, turned a persistent manufacturing bottleneck into a reliable, scalable process.
-
![GettyImages-2235582013-prefilled-syringe-liquid-manufacturing]( "The Need For Adaptive Distribution Partners For Cell And Gene Therapies")
The Need For Adaptive Distribution Partners For Cell And Gene TherapiesOptimize your commercial strategy by exploring how adaptive distribution models navigate reimbursement challenges and improve patient access. Partner early to align workflows and ensure operational success.
-
![GettyImages-1903972230-sustainability-woods-trees-clouds-with-earth]( "Is Sustainability The Key To Agile Biopharma Manufacturing?")
Is Sustainability The Key To Agile Biopharma Manufacturing?In biologics manufacturing, change is constant. Discover how new innovations and a focus on sustainability have gotten 62% of executives to prioritize eco-friendly practices, which reflects a commitment to long-term viability.
-
![GettyImages-941351234-Pharmaceutical_Factory_Worker_Manufacturing_Production_Sterile]( "SaniSure Clamp Pre And Post Gamma Extended Leak Tightness Study")
SaniSure Clamp Pre And Post Gamma Extended Leak Tightness StudyPressure and gamma irradiation testing demonstrated consistent, leak-tight connections without re-tightening for stored single-use assemblies.
-
![GettyImages-1356993441 mRNA]( "mRNA Purification Using Anion Exchange Chromatography At Ambient Temperature")
mRNA Purification Using Anion Exchange Chromatography At Ambient TemperatureExplore how anion exchange chromatography with dual gradient elution enables efficient mRNA purification at ambient temperature.
-
![GettyImages-1832921718-pills-medicine-blue-background]( "Automated Testing For Compound Toxicity Effects")
Automated Testing For Compound Toxicity EffectsExplore how anti-cancer drugs' toxic effects on intestinal cells limit dosages as well as how 3D organoids and assay automation can enhance drug development by improving testing processes.
-
![GettyImages-1346675635-laboratory-analysis-research-microscope]( "Overcoming Analytical Bottlenecks In Oligonucleotide Drug Development With Automation")
Overcoming Analytical Bottlenecks In Oligonucleotide Drug Development With AutomationGrowing oligonucleotide complexity is straining traditional analytical workflows. See how automated LC‑UV‑MS processing offers a scalable way to boost throughput and reduce manual effort.
-
![GettyImages-2183234647 AAV]( "Three-Dimensional Linkage Analysis With Digital PCR For Genome Integrity")
Three-Dimensional Linkage Analysis With Digital PCR For Genome IntegrityA cost-effective approach with a comprehensive AAV analytical package holds the potential to advance the application of rAAV in cell and gene therapy for the treatment of human diseases.
-
![GettyImages-2193981966-dna-helix-built-molecule]( "Rapidly Assess Drug Response In 2D And 3D Breast Cancer Model Systems")
Rapidly Assess Drug Response In 2D And 3D Breast Cancer Model SystemsFor years, 2D cell cultures have been crucial in drug discovery. Explore how 3D cultures offer more biologically relevant models today that enhance cancer research and drug efficacy assessments.
NEWSLETTER ARCHIVE
- 10.05.26 -- Enzyme Activity As A Surrogate Potency Marker In Cell Therapy
- 10.02.26 -- Building Sustainable Biopharma Supply Chains Starts With Procurement
- 10.01.26 -- New Podcast Episodes: 2026 Regulatory Updates, Funding A Virtual Biotech, Structuring CGT Deals
- 10.01.26 -- Building An End-To-End Strategy For CGT Manufacturing
- 10.01.26 -- Why CDMO Capacity Investments Signal A New Era In Cell & Gene
- What LSPA's Life Sciences Future Says About The Road Ahead For CGT
- Inside Scaling Next-Gen MSCs Without Scaling Risk
- Inside Kyverna's Autoimmune CAR T Platform Beyond SPS
- Autoimmune CAR T Has Hit A Critical Moment. Are We Asking The Right Questions?
- Why Celcuity's REVTORPYK Creates A New Path For Precision Oncology
CELL AND GENE CONTENT COLLECTIONS
While there are opportunities to scale, there are also manufacturing gaps, capacity issues, and production timelines that require improvement to do so. And then, of course, there’s cost. Because scale up and scale out are significant to everyone in the sector, we’ve curated insightful editorial that addresses the most important aspects of scalability.
More Content Collections
